Global Blood Transfusion Devices Market Overview:
Blood transfusion is refer as a medical procedure which involves the transferring blood products to the patients to replace the lost parts of the blood. The market of blood transfusion devices is expected to grow in the future due to a high prevalence disorders related to blood and also due to the rise in the incidence of chronic kidney disorders across the globe. Moreover, technological advancements in apheresis systems, blood warmers, infusion pumps, and transfusion filters have facilitated the availability of safe and highly purified blood to patients is boosting the market growth.
Growth Drivers
- Increasing Number of Surgical Procedures
- Rise in the Number of Blood Disorders
Roadblocks
- Stringent Regulatory Framework
Opportunities
- Increasing Infrastructure Developments in Developing Countries
- Rising Healthcare Expenditures
Challenges
- High Costs Associated with the Device
Competitive Landscape:
The Blood Transfusion Devices market is highly competitive and consists of several major players. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with cost-effective pricing.
Some of the key players profiled in the report are Macopharma SA (France), Becton Dickinson (United States), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Abbott Laboratories (United States), Haemonetics Corporation (United States), Fresenius Kabi (Germany), Immucor Inc. (United States), Tenko Medical System Corp (United States), Grifols SA (Spain), Haemonetics Corporation (United States) and Armstrong Medical (United Kingdom). Analyst at AMA Research see United States Players to retain maximum share of Global Blood Transfusion Devices market by 2026. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Blood Transfusion Devices market.
In May 2019, Ecomed Solutions has launched its HEMAsavR device for blood capture and transfer to help medical professionals reduce the costliness of allogeneic blood transfusions.
What Can be Explored with the Blood Transfusion Devices Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Blood Transfusion Devices Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Blood Transfusion Devices
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blood Transfusion Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Blood Transfusion Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Blood Transfusion Devices Manufacturers, Blood Transfusion Devices Distributors/Traders/Wholesalers, Blood Transfusion Devices Subcomponent Manufacturers, Industry Association, Downstream Vendors, Medical Institutes, Government Regulatory Bodies, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.